LAV Fund VI L.P. 13D and 13G filings for ArriVent BioPharma, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:20 pm Purchase | 2024-01-26 | 13G | ArriVent BioPharma, Inc. Common Stock AVBP | LAV Fund VI L.P. | 2,046,123 6.400% | 2,046,123 (New Position) | Filing |